RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (RPID)

CUSIP: 75340L104

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 6 signals
Share change
-669,872
SEC-reported price per share
$10.64
Number of holders
55
Value change
-$13,559,494
Number of buys
33
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,651,578

Security key

75340L104

Report period

Q4 2021

Institutions

55

Top holders

10

Ownership snapshot

Top reported holders of RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gurinder Grewal
Disclosed value leader
Bain Capital Life Science...
Comparable rows
0/15
Latest evidence
30 Sep 2021
3/4/5 13F Highest disclosed value: $155,786,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bain Capital Life Sciences Investors, LLC has the largest disclosed position value at $155.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.
Disclosed position value Top 5
Gurinder Grewal $291.9K
Longitude Prime Partners, LLC $148.4K
Bain Capital Life Sciences Invest... $155.79M
D1 Capital Partners L.P. $48.84M
PRICE T ROWE ASSOCIATES INC /MD/ $33.9M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gurinder Grewal
3/4/5
10%+ Owner
—
denominator unverified
$291,863
294,990 shares
— 19 Jul 2021
Longitude Prime Partners, LLC
3/4/5
10%+ Owner
—
denominator unverified
$148,410
150,000 shares
— 19 Jul 2021
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$155,786,000
8,434,560 shares
— 30 Sep 2021
D1 Capital Partners L.P.
13F
Company
13F
—
denominator unverified
$48,843,000
2,644,444 shares
— 30 Sep 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$33,896,000
1,856,042 shares
— 30 Sep 2021
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$31,108,000
1,684,232 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
55
Shares
21,436,197
Rows available
55
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q2 2026 Across Filers

Q2 2026 holders
35
Q4 2021 holders
55
Holder diff
20
Investor Q2 2026 Shares Q4 2021 Shares Share Diff Share Chg % Q2 2026 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .